These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 20934121

  • 1. A study on pollen allergens in China.
    Liu ZG, Song JJ, Kong XL.
    Biomed Environ Sci; 2010 Aug; 23(4):319-22. PubMed ID: 20934121
    [Abstract] [Full Text] [Related]

  • 2. [Changes in allergen-specific IgG-4 during desensitization of patients with hay fever and those sensitized to housedust allergens].
    Kruszewski J.
    Pneumonol Alergol Pol; 1991 Aug; 59 Suppl 1():31-9. PubMed ID: 1843806
    [No Abstract] [Full Text] [Related]

  • 3. [Hay fever: pollinosis].
    Ado VA, Astaf'eva NG, Goriachkina LA.
    Sov Med; 1981 Aug; (6):61-6. PubMed ID: 7025247
    [No Abstract] [Full Text] [Related]

  • 4. Study on specific immunotherapy with the aid of 3M Diagnostic Systems' tests.
    Stasiak-Barmuta A, Dabrowska I, Piotrowska T, Hofman J.
    Pneumonol Alergol Pol; 1992 Aug; 60 Suppl 1():53-6. PubMed ID: 1292848
    [No Abstract] [Full Text] [Related]

  • 5. [Allergic rhinitis. This year the pollen count is expected to be high].
    Hellmann A.
    MMW Fortschr Med; 2006 May 25; 148(21):51-2. PubMed ID: 16796189
    [No Abstract] [Full Text] [Related]

  • 6. Clinical trials with recombinant allergens--three perspectives: industry.
    Narkus A, Kniest F, Menzel A, Meyer H, Sprung V.
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009 May 25; 96():270-5; discussion 275-8. PubMed ID: 20799471
    [No Abstract] [Full Text] [Related]

  • 7. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study.
    Klimek L, Schendzielorz P, Pinol R, Pfaar O.
    Clin Exp Allergy; 2012 Jun 25; 42(6):936-45. PubMed ID: 22909165
    [Abstract] [Full Text] [Related]

  • 8. Associations among air pollutants, grass pollens, and daily number of grass pollen allergen-positive patients: a longitudinal study from 2012 to 2016.
    Ouyang Y, Yin Z, Li Y, Fan E, Zhang L.
    Int Forum Allergy Rhinol; 2019 Nov 25; 9(11):1297-1303. PubMed ID: 31513736
    [Abstract] [Full Text] [Related]

  • 9. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D.
    Curr Opin Investig Drugs; 2010 May 25; 11(5):586-96. PubMed ID: 20419605
    [Abstract] [Full Text] [Related]

  • 10. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M, Jenerowicz D, Silny W.
    Acta Dermatovenerol Croat; 2008 May 25; 16(1):19-24. PubMed ID: 18358104
    [Abstract] [Full Text] [Related]

  • 11. Survey of airborne pollen in Hubei province of China.
    Liu GH, Zhu RF, Zhang W, Li WJ, Wang ZX, Chen H.
    Chin Med Sci J; 2008 Dec 25; 23(4):212-7. PubMed ID: 19180881
    [Abstract] [Full Text] [Related]

  • 12. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E, Staikuniene J, Scheiblhofer S, Thalhamer J, Kundi M, Westritschnig K, Swoboda I, Flicker S, Valenta R.
    Allergy; 2011 Sep 25; 66(9):1174-82. PubMed ID: 21480924
    [Abstract] [Full Text] [Related]

  • 13. [A survey of main allergic pollen in pollinosis in district of Wuhan].
    Liu G, Huang X, Li H.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 May 25; 12(5):226-7, 230. PubMed ID: 11189163
    [Abstract] [Full Text] [Related]

  • 14. [News on environmental impact on pollen and allergies].
    Behrendt H.
    Krankenpfl J; 2005 May 25; 43(7-10):259. PubMed ID: 16515329
    [No Abstract] [Full Text] [Related]

  • 15. Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study.
    Pfaar O, Barth C, Jaschke C, Hörmann K, Klimek L.
    Int Arch Allergy Immunol; 2011 May 25; 154(4):336-44. PubMed ID: 20975285
    [Abstract] [Full Text] [Related]

  • 16. Pollen-Induced Allergic Asthma and Rhinoconjunctivitis: Differences in Outcome Between Seasonal and Nonseasonal Exposure to Allergens Under Real-Life Conditions (The LANDSCAPE Study).
    Dominguez-Ortega J, Navarro A, Delgado Romero J, Dordal T, Habernau A, Rodríguez M, Mur-Gimeno P, González Gutiérrez ML, Pérez-Francés C, Pascual Miravalles MJ, Colás C, Dávila I, Rodríguez Fernández F, Sánchez Hernández MC, Valero A, LANDSCAPE STUDY GROUP of the SEAIC.
    J Investig Allergol Clin Immunol; 2020 May 25; 30(6):454-456. PubMed ID: 32376518
    [No Abstract] [Full Text] [Related]

  • 17. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals.
    Riediker M, Monn C, Koller T, Stahel WA, Wüthrich B.
    Ann Allergy Asthma Immunol; 2001 Oct 25; 87(4):311-8. PubMed ID: 11686424
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis.
    Pfaar O, Robinson DS, Sager A, Emuzyte R.
    Allergy; 2010 Dec 25; 65(12):1614-21. PubMed ID: 20645937
    [Abstract] [Full Text] [Related]

  • 19. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
    Hylander T, Latif L, Petersson-Westin U, Cardell LO.
    J Allergy Clin Immunol; 2013 Feb 25; 131(2):412-20. PubMed ID: 23374268
    [Abstract] [Full Text] [Related]

  • 20. The dangerous liaison between pollens and pollution in respiratory allergy.
    Schiavoni G, D'Amato G, Afferni C.
    Ann Allergy Asthma Immunol; 2017 Mar 25; 118(3):269-275. PubMed ID: 28143681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.